Morning Edition Hear the Morning Edition program for January 30, 2023

Morning EditionMorning Edition

Wegovy has been called "a major breakthrough" given how well it works to reduce body weight. But the injection drug is extremely expensive and when people can't afford to stay on it, they experience rebound weight gain that's hard to stop. Katherine Streeter for NPR hide caption

toggle caption
Katherine Streeter for NPR

Shots - Health News

Wegovy works. But here's what happens if you can't afford to keep taking the drug

The new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.

Wegovy has been called "a major breakthrough" given how well it works to reduce body weight. But the injection drug is extremely expensive and when people can't afford to stay on it, they experience rebound weight gain that's hard to stop. Katherine Streeter for NPR hide caption

toggle caption
Katherine Streeter for NPR

Wegovy works. But here's what happens if you can't afford to keep taking the drug

  • Download
  • <iframe src="https://www.npr.org/player/embed/1152039799/1152448849" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Searching for a song you heard between stories? We've retired music buttons on these pages. Learn more here.

Morning EditionMorning Edition